Equities research analysts expect Concord Medical Services Hldg Ltd (NYSE:CCM) to report earnings of $0.01 per share for the current quarter, according to Zacks. Zero analysts have made estimates for Concord Medical Services’ earnings. The company is scheduled to report its next quarterly earnings results on Monday, January 1st.
On average, analysts expect that Concord Medical Services will report full-year earnings of $0.06 per share for the current fiscal year. For the next financial year, analysts expect that the firm will post earnings of $0.05 per share. Zacks Investment Research’s EPS averages are an average based on a survey of research firms that cover Concord Medical Services.
Separately, Zacks Investment Research upgraded Concord Medical Services from a “sell” rating to a “hold” rating in a report on Friday.
Shares of CCM traded up $0.06 during mid-day trading on Monday, reaching $3.74. The company’s stock had a trading volume of 4,106 shares, compared to its average volume of 4,308. Concord Medical Services has a 12-month low of $2.46 and a 12-month high of $4.20. The company has a market cap of $159.58 million, a P/E ratio of -3.67 and a beta of 0.63. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.10 and a current ratio of 1.10.
About Concord Medical Services
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.